☰
Skip to content
Home
Studies
BioFINDER One
BioFINDER Two
BioFINDER Sleep
BioFINDER Preclinical AD
BioFINDER Primary Care
BioFINDER Memory Clinic
Study Group
Publications
News
Deltagare / Participants
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.
2024
J Neurol. 2024 Dec 12;272(1):25. doi: 10.1007/s00415-024-12732-3.PMID: 39666133
Eratne D, Li QX, Lewis C, Dang C, Kang MJY, Grewal J, Loi S, Walterfang M, Evans AH, Malpas CB, Pedrini S, Martins R, Chatterjee P, Zetterberg H, Blennow K, Berkovic SF, Santillo AF, Collins S, Masters CL, Velakoulis D; MiND Study Group.
J Neurol. 2024 Dec 12;272(1):25. doi: 10.1007/s00415-024-12732-3.PMID: 39666133
2026
Biological classification of memory clinic patients
2026
Reference proteins to improve Core 1 and Core 2 Alzheimer’s disease CSF and plasma biomarkers
2026
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia
2026
Eligibility for amyloid targeting therapies among primary care patients with cognitive symptoms
2026
Integration of plasma eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer’s disease: a prospective cohort study
2026
Identification of distinct and shared biomarker panels in different manifestations of cerebral small-vessel disease through proteomic profiling
2026
High- and Low-Fat Dairy Consumption and Long-Term Risk of Dementia: Evidence From a 25-Year Prospective Cohort Study
2026
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology
2026
Associations of modifiable and non-modifiable risk factors with longitudinal white matter hyperintensities, amyloid-β and tau – a prospective cohort study
2026
A review of evidence supporting amyloid beta reduction as a surrogate endpoint in Alzheimer’s disease
2025
STEM-PD trial protocol: a multi-centre, single-arm, first-in-human, dose-escalation trial, investigating the safety and tolerability of intraputamenal transplantation of human embryonic stem cell-derived dopaminergic cells for Parkinson’s disease
2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
2025
Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies
2025
Prediction of continuous amyloid positron emission tomography with fluid measures of phosphorylated tau and β-amyloid
2025
Locus coeruleus-entorhinal cortex tract integrity is linked to plasma tau and glial fibrillary acidic protein